Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Decrementing settings for a range of power caps when a power cap is exceeded
Controlling a resource demand system
LCD television set capable of external connection with application processor
Pattern data conversion for lithography system
Semiconductor device and method of manufacturing the same
System and method for converting biomass to ethanol via syngas
  Randomly Featured Patents
Image processing apparatus for gradation processing of an image signal to output a pulse width modulated signal
NMR local coil for brain imaging
Sintered armature
Process for producing N-protected-.alpha.-L-aspartyl-L-phenylalanine methyl ester
Dimerization process
Wireless terminal
Device for sequential observation of samples and methods using same
Web-based speech recognition with scripting and semantic objects
Percutaneous hemostatic suturing device and method